Trial Condition(s):

Pneumonia

CAPRIVI: Community Acquired Pneumonia: Treatment with Avelox® in Hospitalized Patients

Bayer Identifier:

14522

ClinicalTrials.gov Identifier:

NCT00987792

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The aim of this study is to obtain data from hospitalized Community Acquired Pneumonia (CAP) patients on the disease including disease severity, clinical signs and symptoms and measures used for diagnosis in daily routine practice as well as data on Avelox® including information on the use, effectiveness, treatment outcome, safety and tolerability.

As this is a non-interventional observational study, routine clinical practice is observed. The application of medications follows the normal routines and is decided by the treating physician under recognition of the package insert.

Inclusion Criteria
- Adult hospitalized patients with a diagnosis of CAP (based on local medical practice) and decision taken by the investigator to treat with moxifloxacin and to start treatment with intravenous administration. The local moxifloxacin product information must be considered.
Exclusion Criteria
- Contraindications stated in the local moxifloxacin product information; warnings and precautions must be considered.

Trial Summary

Enrollment Goal
2595
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Avelox (Moxifloxacin hydrochloride, BAY12-8039)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Macedonia

Status
Completed
 
Locations

Investigative Site

Many Locations, Croatia

Status
Completed
 
Locations

Investigative Site

Many Locations, Moldova

Status
Completed
 
Locations

Investigative Site

Many Locations, Kazakhstan

Status
Completed
 
Locations

Investigative Site

Many Locations, Hungary

Status
Completed
 
Locations

Investigative Site

Many Locations, Russia

Status
Completed
 
Locations

Investigative Site

Many Locations, Ukraine

Status
Completed
 
Locations

Investigative Site

Many Locations, Romania

Status
Completed
 
Locations

Investigative Site

Many Locations, Jordan

Status
Completed
 
Locations

Investigative Site

Many Locations, Lebanon

Status
Completed
 
Locations

Investigative Site

Many Locations, France

Status
Completed
 

Trial Design